Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: Implications for hypoxia tolerance and perinatal mortality

Developmental Brain Research

Volumn 113, Issue 1-2, 1999, Pages 1-12

  Slotkin, Theodore A ^a   Epps, Tiffany A ^a   Stenger, Maranda L ^a   Sawyer, Kevin J ^a   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenergic receptor; Adenylyl cyclase; Cholinergic receptor; Muscarinic receptor; Nicotinic receptor; Sudden Infant Death Syndrome (SIDS)

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; MUSCARINIC RECEPTOR; NICOTINE;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN STEM; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIA; NEUROTRANSMITTER RELEASE; NONHUMAN; PERINATAL MORTALITY; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SLEEP APNEA SYNDROME; SUDDEN INFANT DEATH SYNDROME;

ADENYLATE CYCLASE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BINDING, COMPETITIVE; BRAIN STEM; FEMALE; HEART; MORTALITY; MYOCARDIUM; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; TRITIUM;

ANIMALIA; NICOTIANA TABACUM;

EID: 0033548646     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00173-4     Document Type: Article

References (66)

1. Bardy A.H., Seppala T., Lillsunde P., Kataja J.M., Koskela P., Pikkarainen J., Hiilesmaa V.K. Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br. J. Obstet. Gynaecol. 100:1993;721-726.
2. Brazell M.P., Mitchell S.N., Gray J.A. Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology. 8:1991;823-833.
3. Chaudhry A., Granneman J.G. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Am. J. Physiol. 261:1991;R403-R411.
4. DiFranza J.R., Lew R.A. Effect of maternal cigarette smoking on pregnancy complications and Sudden Infant Death Syndrome. J. Fam. Pract. 40:1995;385-394.
5. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Human Dev. 3:1979;79-83.
6. Flores C.M., Davila-Garcia M.I., Ulrich Y.M., Kellar K.J. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J. Neurochem. 69:1997;2216-2219.
7. Giannuzzi C.E., Seidler F.J., Slotkin T.A. β-Adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res. 694:1995;271-278.
8. Gootman P.M., Gootman N., Sica A.L. A neuro-cardiac theory for Sudden Infant Death Syndrome: role of the autonomic nervous system. J. Sudden Infant Death Infant Mort. 1:1996;169-182.
9. Grunfeld J.A., Tiedemann G.J., Westerman R.A. Maternal nicotine exposure enhances cutaneous axon reflexes in the neonatal rat. NeuroReport. 4:1993;635-638.
10. Guntheroth W.G. Sudden infant death syndrome (crib death). Am. Heart J. 93:1977;784-792.
11. Hanson M., Calder N., Watanabe T., Kumar P. The drive to breathe and sudden infant death syndrome. Acta Pædiatr. 389:1993;47-49. Suppl.
12. Happe H.K., Murrin L.C. High-affinity choline transport regulation by drug administration during postnatal development. J. Neurochem. 58:1992;2053-2059.
13. Henderson-Smart D.L. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust. Paediatr. J. 17:1981;273-276.
14. Hohmann C.F., Brooks A.R., Coyle J.T. Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development. Dev. Brain Res. 42:1988;253-264.
15. Holgert H., Hökfelt T., Hertzberg T., Lagercrantz H. Functional and developmental studies of the peripheral arterial chemoreceptors in rat: effects of nicotine and possible relation to sudden infant death syndrome. Proc. Natl. Acad. Sci. 92:1995;7575-7579.
16. Isaac P.F., Rand M.J. Cigarette smoking and plasma levels of nicotine. Nature. 236:1972;308-310.
17. Kinney H.C., Filiano J.J., Sleeper L.A., Mandell F., Valdes-Dapena M., White W.F. Decreased muscarinic receptor binding in the arcuate nucleus in sudden infant death syndrome. Science. 269:1995;1446-1450.
18. 2+ channels in rat ventricular muscles. Br. J. Pharmacol. 99:1990;334-339.
19. Krous H. Sudden infant death syndrome: pathology and pathophysiology. Pathol. Annu. 19:1984;1-14.
20. Lagercrantz H., Slotkin T.A. The 'stress' of being born. Sci. Am. 254:1986;100-107.
21. Levin E.D., Torry D., Christopher N.C., Yu X., Einstein G., Schwartz-Bloom R.D. Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? Brain Res. Bull. 43:1997;295-304.
22. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73:1988;137-157.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-270.
24. McMillian M.K., Schanberg S.M., Kuhn C.M. Ontogeny of rat hepatic adrenoceptors. J. Pharmacol. Exp. Ther. 227:1983;181-186.
25. Milerad J., Larsson H., Lin J., Sundell H.W. Nicotine attenuates the ventilatory response to hypoxia in the developing lamb. Pediatr. Res. 37:1995;652-660.
26. Mills E. Time course for development of vagal inhibition of the heart in neonatal rats. Life Sci. 23:1978;2717-2720.
27. Murrin L.C., Ferrer J.R., Wanyun Z., Haley N.J. Nicotine administration to rats: methodological considerations. Life Sci. 40:1987;1699-1708.
28. Murrin L.C., Ferrer J.R., Zeng W. Nicotine administration during pregnancy and its effect on striatal development. Neurosci. Abstr. 11:1985;69.
29. Nasrat H.A., Al-Hachim G.M., Mahmood F.A. Perinatal effects of nicotine. Biol. Neonate. 49:1986;8-14.
30. Navarro H.A., Kudlacz E.M., Kavlock R.J., Slotkin T.A. Prenatal terbutaline treatment: tissue-selective dissociation of perinatal changes in β-adrenergic receptor binding from regulation of adenylate cyclase activity. Life Sci. 48:1991;269-274.
31. Navarro H.A., Kudlacz E.M., Slotkin T.A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate. 60:1991;127-136.
32. Navarro H.A., Mills E., Seidler F.J., Baker F.E., Lappi S.E., Tayyeb M.I., Spencer J.R., Slotkin T.A. Prenatal nicotine exposure impairs β-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res. Bull. 25:1990;233-237.
33. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., Slotkin T.A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251:1989;894-900.
34. Navarro H.A., Seidler F.J., Schwartz R.D., Baker F.E., Dobbins S.S., Slotkin T.A. Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res. Bull. 23:1989;187-192.
35. Navarro H.A., Seidler F.J., Whitmore W.L., Slotkin T.A. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J. Pharmacol. Exp. Ther. 244:1988;940-944.
36. 1-receptors. Res. Commun. Substance Abuse. 11:1990;95-103.
37. 1-adrenergic receptors in the rat myocardium: effects of hypothyroidism. Eur. J. Pharmacol. 86:1983;43-50.
38. 1-adrenergic receptor in the rat. Dev. Pharmacol. Ther. 3:1981;179-188.
39. Peters D.A.V. Prenatal nicotine exposure increases adrenergic receptor binding in the rat cerebral cortex. Res. Commun. Chem. Pathol. Pharmacol. 46:1984;307-317.
40. Quigley K.S., Shair H.N., Myers M.M. Parasympathetic control of heart period during early postnatal development in the rat. J. Auton. Nerv. Syst. 59:1996;75-82.
41. Ribary U., Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J. Pharmacol. Exp. Ther. 248:1989;786-792.
42. Schwartz P.J., Stramba-Badiale M., Segantini A., Austoni P., Bosi G., Giorgetti R., Grancini F., Marni E.D., Perticone F., Rosti D., Salice P. Prolongation of the QT interval and the Sudden Infant Death Syndrome. New Engl. J. Med. 338:1998;1709-1714.
43. Seamon K.B., Daly J.W. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20:1986;1-150.
44. Seidler F.J., Levin E.D., Lappi S.E., Slotkin T.A. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. Dev. Brain Res. 69:1992;288-291.
45. Seidler F.J., Slotkin T.A. Adrenomedullary function in the neonatal rat: responses to acute hypoxia. J. Physiol. 358:1985;1-16.
46. T.A. Slotkin, Prenatal exposure to nicotine: what can we learn from animal models? in: I.S. Zagon, T.A. Slotkin (Eds.), Maternal Substance Abuse and the Developing Nervous System, Academic Press, San Diego, 1992, pp. 97-124.
47. Slotkin T.A., Lappi S.E., McCook E.C., Lorber B.A., Seidler F.J. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for Sudden Infant Death Syndrome. Brain Res. Bull. 38:1995;69-75.
48. Slotkin T.A., Lappi S.E., Seidler F.J. Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? Brain Res. Bull. 31:1993;319-328.
49. Slotkin T.A., Lau C., McCook E.C., Lappi S.E., Seidler F.J. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization? Toxicol. Appl. Pharmacol. 127:1994;64-75.
50. Slotkin T.A., McCook E.C., Lappi S.E., Seidler F.J. Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Dev. Brain Res. 68:1992;233-239.
51. Slotkin T.A., Navarro H.A., McCook E.C., Seidler F.J. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci. 47:1990;1561-1567.
52. 3H ]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions J. Pharmacol. Exp. Ther. 242:1987;232-237.
53. Slotkin T.A., Orband-Miller L., Queen K.L., Whitmore W.L., Seidler F.J. Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J. Pharmacol. Exp. Ther. 240:1987;602-611.
54. Slotkin T.A., Saleh J.L., McCook E.C., Seidler F.J. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for Sudden Infant Death Syndrome. Teratology. 55:1997;177-184.
55. G.W. Snedecor, W.G. Cochran, Statistical Methods, Iowa State Univ. Press, Ames, IA, 1967.
56. Song X., Seidler F.J., Saleh J.L., Zhang J., Padilla S., Slotkin T.A. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol. Appl. Pharmacol. 145:1997;158-174.
57. Southall D.P., Noyes J.P., Poets C.F., Samuels M.P. Mechanisms for hypoxæmic episodes in infancy and early childhood. Acta Pædiat. 389:1993;60-62. Suppl.
58. Tolson C.M., Seidler F.J., McCook E.C., Slotkin T.A. Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage? Teratology. 52:1995;298-305.
59. M.A. Valdes-Dapena, Sudden infant death syndrome: a review of the medical literature, DHHS Publication HSA 81-5271 (1981) 1-18.
60. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation. Trends Pharmacol. Sci. 11:1990;216-219.
61. Yanai J., Pick C.G., Rogel-Fuchs Y., Zahalka E.A. Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine. Brain Res. Bull. 29:1992;363-368.
62. Yoshida K., Kato Y., Imura H. Nicotine-induced release of noradrenaline from hypothalamic synaptosomes. Brain Res. 182:1980;361-368.
63. Zahalka E.A., Seidler F.J., Yanai J., Slotkin T.A. Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins. Neurotoxicol. Teratol. 15:1993;107-115.
64. Zeiders J.L., Seidler F.J., Slotkin T.A. Ontogeny of regulatory mechanisms for β-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J. Mol. Cell. Cardiol. 29:1997;603-615.
65. Zhu J., Takita M., Konishi Y., Sudo M., Muramatsu I. Chronic nicotine treatment delays the developmental increase in brain muscarinic receptors in rat neonate. Brain Res. 732:1996;257-260.
66. Zhu J., Taniguchi T., Konishi Y., Mayumi M., Muramatsu I. Nicotine administration decreases the number of binding sites and mRNA of M-1 and M-2 muscarinic receptors in specific brain regions of rat neonates. Life Sci. 62:1998;1089-1098.